113 related articles for article (PubMed ID: 31750758)
1. Delivery of pemetrexed by magnetic nanoparticles: design, characterization,
Ak G; Aksu D; Çapkın E; Sarı Ö; Kımız Geboloğlu I; Şanlıer ŞH
Prep Biochem Biotechnol; 2020; 50(3):215-225. PubMed ID: 31750758
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo.
Yang W; Yang L; Xia Y; Cheng L; Zhang J; Meng F; Yuan J; Zhong Z
Acta Biomater; 2018 Apr; 70():177-185. PubMed ID: 29410335
[TBL] [Abstract][Full Text] [Related]
3. High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.
Kuo WT; Tu DG; Chiu LY; Sheu GT; Wu MF
Oncol Rep; 2017 Nov; 38(5):2787-2795. PubMed ID: 28901493
[TBL] [Abstract][Full Text] [Related]
4. Development of Ultrasound-Triggered and Magnetic-Targeted Nanobubble System for Dual-Drug Delivery.
Hamarat Şanlıer Ş; Ak G; Yılmaz H; Ünal A; Bozkaya ÜF; Tanıyan G; Yıldırım Y; Yıldız Türkyılmaz G
J Pharm Sci; 2019 Mar; 108(3):1272-1283. PubMed ID: 30773203
[TBL] [Abstract][Full Text] [Related]
5. A Supramolecular Nanoparticle of Pemetrexed Improves the Anti-Tumor Effect by Inhibiting Mitochondrial Energy Metabolism.
Liu H; Guo C; Shang Y; Zeng L; Jia H; Wang Z
Front Bioeng Biotechnol; 2021; 9():804747. PubMed ID: 34993192
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone alleviates pemetrexed-induced senescence in Non-Small-Cell Lung Cancer.
Ge H; Ke J; Xu N; Li H; Gong J; Li X; Song Y; Zhu H; Bai C
Food Chem Toxicol; 2018 Sep; 119():86-97. PubMed ID: 29753869
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide (NO) enhances pemetrexed cytotoxicity via NO‑cGMP signaling in lung adenocarcinoma cells in vitro and in vivo.
Nagai H; Yasuda H; Hatachi Y; Xue D; Sasaki T; Yamaya M; Sakamori Y; Togashi Y; Masago K; Ito I; Kim YH; Mio T; Mishima M
Int J Oncol; 2012 Jul; 41(1):24-30. PubMed ID: 22552400
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and antimetastatic effects of pemetrexed-loaded targeted nanoparticles in B
Lu N; Li R; Liu Q; Hu B; Xu X; Ji C; Han X; Wang P; Liu B
Drug Deliv; 2016 Sep; 23(7):2566-2574. PubMed ID: 26000825
[TBL] [Abstract][Full Text] [Related]
10. Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation.
Huang WT; Larsson M; Wang YJ; Chiou SH; Lin HY; Liu DM
Mol Pharm; 2015 Apr; 12(4):1242-9. PubMed ID: 25760774
[TBL] [Abstract][Full Text] [Related]
11. Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer.
Yu X; Wu H; Hu H; Dong Z; Dang Y; Qi Q; Wang Y; Du S; Lu Y
Drug Deliv; 2020 Dec; 27(1):100-109. PubMed ID: 31870183
[No Abstract] [Full Text] [Related]
12. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
[TBL] [Abstract][Full Text] [Related]
13. Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.
Huang G; Zang B; Wang X; Liu G; Zhao J
Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):981-7. PubMed ID: 26525950
[TBL] [Abstract][Full Text] [Related]
14. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.
Wu H; Zhong Q; Zhong R; Huang H; Xia Z; Ke Z; Zhang Z; Song J; Jia X
Int J Nanomedicine; 2016; 11():6337-6352. PubMed ID: 27932881
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts.
Cui J; Zhang Y; Su D; Li T; Li Y
Thorac Cancer; 2018 Sep; 9(9):1156-1165. PubMed ID: 30047610
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells.
Okimoto T; Kotani H; Iida Y; Koyanagi A; Tanino R; Tsubata Y; Isobe T; Harada M
Cancer Sci; 2020 Jun; 111(6):1910-1920. PubMed ID: 32232903
[TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
[TBL] [Abstract][Full Text] [Related]
18. Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients.
Honoré PH; Joensen SJ; Olsen M; Hansen SH; Mellemgaard A
Cancer Chemother Pharmacol; 2014 Aug; 74(2):349-57. PubMed ID: 24934863
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
20. One Pot Green Synthesis of Doxorubicin and Curcumin Loaded Magnetic Nanoparticles and Cytotoxicity Studies.
Ak G; Karakayalı T; Cin AN; Özel B; Şanlıer ŞH
Anticancer Agents Med Chem; 2021; 21(18):2563-2571. PubMed ID: 33438561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
